FludeoxyglucoseF18 (The University of Texas MD Anderson Cancer Center)
Welcome to the PulseAid listing for the Fludeoxyglucose drug offered from The University of Texas MD Anderson Cancer Center. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | The University of Texas MD Anderson Cancer Center |
NON-PROPRIETARY NAME: | Fludeoxyglucose F18 |
SUBSTANCE NAME: | FLUDEOXYGLUCOSE F-18 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-06 |
END MARKETING DATE: | 0000-00-00 |
Fludeoxyglucose F18 HUMAN PRESCRIPTION DRUG Details:
Item Description | Fludeoxyglucose F18 from The University of Texas MD Anderson Cancer Center |
LABELER NAME: | The University of Texas MD Anderson Cancer Center |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mCi/mL) |
START MARKETING DATE: | 2011-12-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60215-411_44e88293-40d9-4f81-8899-cf38774b2a87 |
PRODUCT NDC: | 60215-411 |
APPLICATION NUMBER: | ANDA203246 |
Other FLUDEOXYGLUCOSE F-18 Pharmaceutical Manufacturers / Labelers:
Manufacturer / Labeler | Proprietary Name |
Biomedical Research Foundation of Northwest Louisiana | Fludeoxyglucose |
BRIGHAM AND WOMEN`S HOSPITAL, INC., THE | FLUDEOXYGLUCOSE F-18 |
Cardinal Health 414, LLC | Fludeoxyglucose F-18 |
Centre for Probe Development and Commercialization | Fludeoxyglucose F 18 |
Children’s Hospital of Michigan | Fludeoxyglucose F 18 |
Cyclotron Partners LP dba Cyclotope | Fludeoxyglucose |
Essential Isotopes LLC | Fludeoxyglucose F18 |
Global Isotopes, LLC d/b/a Zevacor Molecular | Fludeoxyglucose F 18 |
Hamamatsu/Queens PET Imaging Center, LLC | Fludeoxyglucose F 18 |
Hot Shots NM, LLC dba Midwest Positron Technology, LC | Fludeoxyglucose F 18 |
JUBILANT DRAX IMAGE RADIOPHARMACIES, INC. DBA TRIAD ISOTOPES | Fludeoxyglucose F 18 |
Lantheus Medical Imaging, Inc. | Fludeoxyglucose F-18 |
Massachusetts General Hospital | Fludeoxyglucose F 18 |
Mayo Clinic | Fludeoxyglucose F 18 |
Memorial Sloan Kettering Cancer Center | Fludeoxyglucose F18 |
MIPS Cyclotron & Radiochemistry Facility | Fludeoxyglucose |
NCM-USA Bronx LLC | Fludeoxyglucose F 18 |
PETNET Solutions, Inc. | Fludeoxyglucose F 18 |
Precision Nuclear LLC | Fludeoxyglucose F-18 |
Shertech Laboratories, LLC | Fludeoxyglucose F-18 |
Spectron mrc, LLC | Fludeoxyglucose F 18 |
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH | Fludeoxyglucose F18 |
The Methodist Hospital Research Institute | Fludeoxyglucose F18 |
The Regents of the University of Michigan | Fludeoxyglucose |
The University of Texas MD Anderson Cancer Center | Fludeoxyglucose |
The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute | Fludeoxyglucose F 18 |
Trustees of the University of Pennsylvania | Fludeoxyglucose F-18 |
UCSF Radiopharmaceutical Facility | Fludeoxyglucose F18 |
UIHC-P E T IMAGING CENTER | FLUDEOXYGLUCOSE F 18 |
University of California, Los Angeles | Fludeoxyglucose F 18 |
University of North Dakota | Fludeoxyglucose F-18 |
Washington University School of Medicine | Fludeoxyglucose F 18 |
Wisconsin Medical Cyclotron LLC | Fludeoxyglucose F18 |
Zevacor Pharma, Inc. | Fludeoxyglucose F 18 |